Category archives for Scientific Integrity
Senator Bill Nelson (D-FL), joined by 26 of his colleagues, has introduced the Scientific Integrity Act (S 338), which would require agencies that conduct or fund scientific research to develop and enforce scientific integrity policies.
In action that may portend how the 114th Congress will treat science, the House has passed two bills that would limit the EPA’s use of science. The White House is threatening to veto both – and an additional bill that in the White House’s view could weaken the Clean Air Act’s public health and environmental protections.
The scheming by Jackson Kelly attorneys to deny coal miners with black lung disease modest compensation is immoral. If coal companies are sincere about their workers being their “most precious resource,” they should dump the law firm.
UCLA Professor Emeritus John Froines was awarded this week the 2013 Ramazzini Award from the internationally renowned Collegium Ramazzini. Professor Froines’ work represents the best of public health research: solid science with the highest integrity for the benefit of groups with little economic and political power.
The worlds of Georgia-Pacific, asbestos-litigation, scientific journals, and OSHA all fell together last week under the umbrella of transparency and disclosure.
On October 17, the World Health Organization’s International Agency for Research on Cancer (IARC) announced that it has classified air pollution as a human carcinogen. Although the composition of air pollution and exposure levels vary widely from place to place, IARC says its assessment is applicable worldwide and notes that exposures in rapidly industrializing countries…
For the first time in OSHA’s rulemaking history, the agency is requesting that those submitting studies, reports and analysis on its proposed silica standard disclose potential conflicts of interest.
How do Edward Snowden and his revelations impinge on public health and its practice, in the US and around the world? In their Editorial, “Least Untruthful, a new standard?” the Co-Editors of the Journal of Public Health Policy have spelled out some important implications for public health.
For years, Peter Rosenfeld was looking for an effective way to treat what doctors had diagnosed as severe and intractable migraines. He’d heard of medical marijuana, but thought it was a joke — that it was just a way for people to justify their marijuana use. Today, he’s a passionate advocate for medicinal marijuana and one of many advocates disappointed at recent federal actions.
In the New York Times last week, Gardiner Harris reported on tensions between FDA and the White House over FDA decisions that White House officials fear will be politically problematic for President Obama. Harris reminds readers that “The Bush administration repeatedly stopped the agency from issuing rules to prevent contamination of eggs, produce and other…